<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="research-article" xmlns:xlink="http://www.w3.org/1999/xlink">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Molecular Medicine Reports</journal-id>
<journal-title-group>
<journal-title>Molecular Medicine Reports</journal-title>
</journal-title-group>
<issn pub-type="ppub">1791-2997</issn>
<issn pub-type="epub">1791-3004</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/mmr.2021.12050</article-id>
<article-id pub-id-type="publisher-id">MMR-0-0-12050</article-id>
<article-categories>
<subj-group>
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Costunolide attenuates oxygen-glucose deprivation/reperfusion-induced mitochondrial-mediated apoptosis in PC12 cells</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Meng</surname><given-names>Lanqing</given-names></name>
<xref rid="af1-mmr-0-0-12050" ref-type="aff">1</xref>
<xref rid="af2-mmr-0-0-12050" ref-type="aff">2</xref>
<xref rid="fn1-mmr-0-0-12050" ref-type="author-notes">&#x002A;</xref></contrib>
<contrib contrib-type="author"><name><surname>Ma</surname><given-names>Huixia</given-names></name>
<xref rid="af1-mmr-0-0-12050" ref-type="aff">1</xref>
<xref rid="af2-mmr-0-0-12050" ref-type="aff">2</xref>
<xref rid="fn1-mmr-0-0-12050" ref-type="author-notes">&#x002A;</xref></contrib>
<contrib contrib-type="author"><name><surname>Meng</surname><given-names>Jinni</given-names></name>
<xref rid="af1-mmr-0-0-12050" ref-type="aff">1</xref>
<xref rid="af2-mmr-0-0-12050" ref-type="aff">2</xref>
<xref rid="fn1-mmr-0-0-12050" ref-type="author-notes">&#x002A;</xref></contrib>
<contrib contrib-type="author"><name><surname>Li</surname><given-names>Tingting</given-names></name>
<xref rid="af1-mmr-0-0-12050" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author"><name><surname>Zhu</surname><given-names>Yafei</given-names></name>
<xref rid="af1-mmr-0-0-12050" ref-type="aff">1</xref>
<xref rid="af3-mmr-0-0-12050" ref-type="aff">3</xref>
<xref rid="c2-mmr-0-0-12050" ref-type="corresp"/></contrib>
<contrib contrib-type="author"><name><surname>Zhao</surname><given-names>Qipeng</given-names></name>
<xref rid="af1-mmr-0-0-12050" ref-type="aff">1</xref>
<xref rid="af2-mmr-0-0-12050" ref-type="aff">2</xref>
<xref rid="c1-mmr-0-0-12050" ref-type="corresp"/></contrib>
</contrib-group>
<aff id="af1-mmr-0-0-12050"><label>1</label>Key Laboratory of Hui Ethnic Medicine Modernization, Ministry of Education, Ningxia Medical University, Yinchuan, Ningxia Hui Autonomous Region 750004, P.R. China</aff>
<aff id="af2-mmr-0-0-12050"><label>2</label>Department of Pharmacology, Ningxia Medical University, Yinchuan, Ningxia Hui Autonomous Region 750004, P.R. China</aff>
<aff id="af3-mmr-0-0-12050"><label>3</label>College of Basic Medicine, Ningxia Medical University, Yinchuan, Ningxia Hui Autonomous Region 750004, P.R. China</aff>
<author-notes>
<corresp id="c1-mmr-0-0-12050"><italic>Correspondence to</italic>: Professor Qipeng Zhao, Key Laboratory of Hui Ethnic Medicine Modernization, Ministry of Education, Ningxia Medical University, 1160 Shengli Street, Xingqing, Yinchuan, Ningxia Hui Autonomous Region 750004, P.R. China, E-mail: <email>zhqp623@126.com</email></corresp>
<corresp id="c2-mmr-0-0-12050">Dr Yafei Zhu, College of Basic Medicine, Ningxia Medical University, 1160 Shengli Street, Xingqing, Yinchuan, Ningxia Hui Autonomous Region 750004, P.R. China, E-mail: <email>867453132@qq.com</email></corresp>
<fn id="fn1-mmr-0-0-12050"><label>&#x002A;</label><p>Contributed equally</p></fn></author-notes>
<pub-date pub-type="ppub">
<month>06</month>
<year>2021</year></pub-date>
<pub-date pub-type="epub">
<day>30</day>
<month>03</month>
<year>2021</year></pub-date>
<volume>23</volume>
<issue>6</issue>
<elocation-id>411</elocation-id>
<history>
<date date-type="received"><day>22</day><month>11</month><year>2020</year></date>
<date date-type="accepted"><day>04</day><month>03</month><year>2021</year></date>
</history>
<permissions>
<copyright-statement>Copyright: &#x00A9; Meng et al.</copyright-statement>
<copyright-year>2021</copyright-year>
<license license-type="open-access">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">Creative Commons Attribution-NonCommercial-NoDerivs License</ext-link>, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.</license-p></license>
</permissions>
<abstract>
<p>The present study investigated the effect of costunolide (CT), a compound extracted from <italic>Aucklandia lappa</italic> Decne, to attenuate oxygen-glucose deprivation/reperfusion (OGD/R)-induced mitochondrial-mediated apoptosis in PC12 cells. The present study used molecular docking technology to detect the binding of CT with mitochondrial apoptotic protein targets. A model of oxygen-glucose deprivation for 2 h and reperfusion for 24 h in PC12 cells was used to mimic cerebral ischemic injury. Cell viability and damage were measured using the Cell Counting kit-8 and lactate dehydrogenase (LDH) cytotoxicity assay kits. Cellular apoptosis was analyzed using flow cytometry. A fluorescence microscope determined intracellular [Ca<sup>2&#x002B;</sup>] and mitochondrial membrane potential. Furthermore, immunofluorescence and Western blot analyses were used to detect the expression of apoptosis-associated proteins. CT contains binding sites with Caspase-3, Caspase-9 and Caspase-7. CT markedly enhanced cell viability, inhibited LDH leakage, increased intracellular [Ca<sup>2&#x002B;</sup>], stabilized the mitochondrial membrane potential, increased the expression of Bcl-2 and inhibited the expression of Apaf-1, Bax, cleaved-caspase-7, cleaved-caspase-9 and cleaved-caspase-3. CT may markedly protect PC12 cells from damage caused by OGD/R, and its mechanism is associated with blocking the calcium channel and inhibiting mitochondrial-mediated apoptosis.</p>
</abstract>
<kwd-group>
<kwd>costunolide</kwd>
<kwd>ischemic stroke</kwd>
<kwd>oxygen-glucose deprivation/reperfusion</kwd>
<kwd>apoptosis</kwd>
<kwd>caspase</kwd>
<kwd>PC12 cells</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>National Natural Science Foundation of Ningxia</funding-source>
<award-id>2020AAC02017</award-id>
</award-group>
<award-group>
<funding-source>National Natural Science Foundation of China<named-content content-type="funder-id">http://dx.doi.org/10.13039/501100001809</named-content></funding-source>
<award-id>81660700</award-id>
</award-group>
<funding-statement>The present study was supported by the National Natural Science Foundation of Ningxia (grant no. 2020AAC02017) and the National Natural Science Foundation of China (grant no. 81660700).</funding-statement>
</funding-group>
</article-meta>
</front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>Ischemic stroke is one of the most important causes of death and disability worldwide (<xref rid="b1-mmr-0-0-12050" ref-type="bibr">1</xref>,<xref rid="b2-mmr-0-0-12050" ref-type="bibr">2</xref>). In China, stroke became the top leading cause of mortality in 2017. Approximately 1.5 million people die from strokes each year (<xref rid="b3-mmr-0-0-12050" ref-type="bibr">3</xref>). In ischemic stroke, the insufficient supply of oxygen and glucose causes brain damage within the subsequent few hours (<xref rid="b4-mmr-0-0-12050" ref-type="bibr">4</xref>,<xref rid="b5-mmr-0-0-12050" ref-type="bibr">5</xref>). The primary method is to restore the blood supply of ischemic brain tissue as soon as possible. However, the reopening of the occluded cerebrovascular usually leads to pathological damage in the ischemic tissue, which may further aggravate or potentially make the damage irreversible. Neuronal injury caused by ischemia/reperfusion is a complex process involving various mechanisms, including apoptosis, oxygen-free radicals, glutamic acid toxicity and [Ca<sup>2&#x002B;</sup>] overload (<xref rid="b6-mmr-0-0-12050" ref-type="bibr">6</xref>). It remains an area of interest to perform drug research on stroke treatment (<xref rid="b7-mmr-0-0-12050" ref-type="bibr">7</xref>).</p>
<p>Apoptosis is an essential mechanism of ischemic stroke (<xref rid="b8-mmr-0-0-12050" ref-type="bibr">8</xref>,<xref rid="b9-mmr-0-0-12050" ref-type="bibr">9</xref>). Apoptosis is regulated through the death receptor pathway, mitochondrial pathway and endoplasmic reticulum pathway. In the majority of vertebrates, apoptosis is regulated by the mitochondrial pathway (<xref rid="b10-mmr-0-0-12050" ref-type="bibr">10</xref>,<xref rid="b11-mmr-0-0-12050" ref-type="bibr">11</xref>). Mitochondria are the active centers of apoptosis regulation and the executors (<xref rid="b12-mmr-0-0-12050" ref-type="bibr">12</xref>). The pro-apoptotic factor causes the mitochondrial permeability transition pore (MPTP) to open excessively, decreasing the membrane potential, releasing cytochrome c from the mitochondria to the cytosol. Next, caspase is activated and cells undergo apoptosis (<xref rid="b13-mmr-0-0-12050" ref-type="bibr">13</xref>,<xref rid="b14-mmr-0-0-12050" ref-type="bibr">14</xref>).</p>
<p>Mu-Xiang-You prescription is a classic prescription of Hui medicine, which affects ischemic stroke (<xref rid="b15-mmr-0-0-12050" ref-type="bibr">15</xref>). <italic>Aucklandia lappa</italic> Decne is the main drug in the prescription (45&#x0025; by weight); therefore, we hypothesized that <italic>Aucklandia lappa</italic> Decne is an essential drug in treating ischemic stroke. CT (C<sub>15</sub>H<sub>20</sub>O<sub>2</sub>; <xref rid="f1-mmr-0-0-12050" ref-type="fig">Fig. 1</xref>), an active sesquiterpene lactone, is one of the main useful components of <italic>Aucklandia lappa</italic> Decne. CT is used to control the quality of <italic>Aucklandia lappa</italic> Decne in Chinese Pharmacopoeia. We hypothesized that the effect of this prescription in the treatment of ischemic stroke is associated with CT. CT has multiple pharmacological activities, including inhibiting tumour cell proliferation (<xref rid="b16-mmr-0-0-12050" ref-type="bibr">16</xref>) and decreasing the inflammatory response (<xref rid="b17-mmr-0-0-12050" ref-type="bibr">17</xref>,<xref rid="b18-mmr-0-0-12050" ref-type="bibr">18</xref>). However, it is unclear whether CT may attenuate cerebral ischemia/reperfusion injury and its anti-apoptosis mechanism. Therefore, the present study aimed to investigate the effects of CT and mechanisms on OGD/R-induced PC12 cell injury.</p>
</sec>
<sec sec-type="materials|methods">
<title>Materials and methods</title>
<sec>
<title/>
<sec>
<title>Drugs and reagents</title>
<p>CT (cat. no. 447-43-0) was provided by the PUSH Bio-Technology. Fetal bovine serum and Dulbecco&#x0027;s modified Eagle&#x0027;s medium (DMEM) were offered by Gibco (Thermo Fisher Scientific, Inc.). Streptomycin and penicillin were purchased from HyClone (GE Healthcare Life Sciences). Nimodipine injection (cat. no. 12301323) was provided by Bayer Schering Pharma AG. Lactate dehydrogenase (LDH) assay kit (cat. no. 20090723), total protein extraction (cat. no. 20150323) and BCA protein quantification kits (kit no. 20150323) were provided by Nanjing Jiancheng Bioengineering Institute. ZSGB-BIO supplied horseradish peroxidase-conjugated goat anti-rabbit IgG secondary antibody (cat. no. ZB-2301). Primary antibodies against &#x03B1;-tubulin (cat. no. 2148), Apaf-1 (cat. no. 8723), Bcl-2 (cat. no. 2876) and Bax (cat. no. 2772) were provided by Cell Signaling Technology, Inc. Antibodies against procaspase-9 (cat. no. ab2013), procaspase-7 (cat. no. ab25900), cleaved-caspase-3 (cat. no. ab32042) and procaspase-3 (cat. no. ab44976) were provided by Abcam. Cleaved-caspase-7 (cat. no. AF4203), cleaved-caspase-9 (cat. no. AF5240) were supplied by Affinity Biosciences.</p>
</sec>
<sec>
<title>Molecular docking</title>
<p>The mol2, a molecular structure recording format designed by Sybyl molecular simulation software (version no. 2.1.1; Certara), the mol2 format of CT was downloaded from PubChem (<uri xlink:href="http://pubchem.ncbi.nlm.nih.gov">http://pubchem.ncbi.nlm.nih.gov</uri>). CT and its interacting protein crystals (the structure is a protein complex with an inhibitor) were introduced into the Maestro 11.1 software ligprep module (Schr&#x00F6;dinger, Inc.). The energy optimization of CT in the first field (OPLS-2005) was minimized. The structures of caspase-9, caspase-3 and caspase-7 with endogenous ligands were obtained from the Protein Data Bank. Using the Maestro 11.1 software Glide module, the target protein is modified, dehydrated and hydrogenated under default parameters. The active site of docking is generated by centering on the original ligand. Finally, CT is molecularly docked with the target protein (<xref rid="f2-mmr-0-0-12050" ref-type="fig">Fig. 2</xref>).</p>
</sec>
<sec>
<title>Cell culture</title>
<p>The PC12 cells were obtained from the rat adrenal medulla of pheochromocytoma and have been widely used as an <italic>in vitro</italic> cellular model of neurological diseases and cell signal transduction pathways due to its sympathetic neuron&#x0027;s physiological characteristics. PC12 cells were provided by the Chinese Academy of Sciences Shanghai Cell Biology Institute. PC12 cells were cultured in high-glucose DMEM supplemented with 5&#x0025; fetal calf serum, streptomycin (100 &#x00B5;g/ml), penicillin (100 U/ml) and 5&#x0025; CO<sub>2</sub> at 37&#x00B0;C (<xref rid="b19-mmr-0-0-12050" ref-type="bibr">19</xref>,<xref rid="b20-mmr-0-0-12050" ref-type="bibr">20</xref>).</p>
</sec>
<sec>
<title>Drug treatment</title>
<p>A stock solution was prepared using dimethyl sulfoxide, CT concentrations were set at 2.5, 5 and 10 &#x00B5;M according to our preliminary experimental results. Nimodipine is a calcium channel blocker, and it was used as a positive control drug in this experiment at a concentration of 5 &#x00B5;M (<xref rid="b21-mmr-0-0-12050" ref-type="bibr">21</xref>). Prior to the investigation, the cells were inoculated in culture plates at a density of 1.0&#x00D7;10<sup>5</sup> cells/ml. After 12 h of adhering, to initiate oxygen-glucose deprivation (OGD) by replacing the cell culture medium with the glucose-free medium, the cells were incubated for 2 h in an oxygen-free chamber (5&#x0025; CO<sub>2</sub>; 95&#x0025; N<sub>2</sub>) at 37&#x00B0;C. At the end of the OGD period, the cells were incubated under normal growth conditions (5&#x0025; CO<sub>2</sub> and 95&#x0025; O<sub>2</sub>) for 24 h to achieve reperfusion (R) (<xref rid="b22-mmr-0-0-12050" ref-type="bibr">22</xref>). Cells in the experimental groups were treated with CT (2.5, 5 or 10 &#x00B5;M) and Nimodipine (5 &#x00B5;M) during the entire period of OGD/R.</p>
</sec>
<sec>
<title>Morphological changes in cells</title>
<p>Following OGD/R, the cells were washed three times with PBS, and the inverted microscope (Olympus Corporation; TH4-200; magnification, &#x00D7;200) was used to capture the images.</p>
</sec>
<sec>
<title>CCK-8 assay and LDH release assay</title>
<p>A CCK-8 assay measured the cell viability, according to the manufacturer&#x0027;s protocols. PC12 cells were cultured in 96-well plates (1&#x00D7;10<sup>4</sup> cells/well) and, following OGD/R, CCK-8 (10 &#x00B5;l per well) was added, and cells were incubated for 4 h at 37&#x00B0;C. The OD value at the wavelength of 450 nm was detected by an enzyme labeling instrument.</p>
<p>Cytotoxicity was assessed by measuring the level of LDH in the culture medium. Following reperfusion, the medium was collected for LDH level measurement. The LDH level was measured by spectrophotometry determination at 440 nm, according to the manufacturer&#x0027;s protocol. The release of LDH reflects the degree of cell damage.</p>
</sec>
<sec>
<title>Flow cytometric apoptosis assay</title>
<p>The percentage of the apoptotic cells was determined using an Annexin V-FITC/PI kit (Nanjing KeyGen Biotech Co., Ltd.). The PC12 cells were cultured in 6-well plates (1&#x00D7;10<sup>6</sup> cells/well), washed twice with ice-cold PBS following treatment, collected by trypsinization without EDTA. Next, cells were suspended in 400 &#x00B5;l 1X Annexin V and then Annexin V-FITC staining fluid 5 &#x00B5;l was added in the dark, at 4&#x00B0;C for 15 min, prior to 10 &#x00B5;l PI staining fluid being added at 4&#x00B0;C for 5 min. Finally, the cells were analyzed by flow cytometry (BD Biosciences) using BD Accuri C6 software (version no. 1.0.264.21; BD Biosciences) The total apoptosis rate is equal to the early apoptotic rate plus the dead cells rate.</p>
</sec>
<sec>
<title>Mitochondrial membrane potential (MMP) measurement</title>
<p>Disruption of the MMP is one of the earliest intracellular changes following apoptosis induction (<xref rid="b19-mmr-0-0-12050" ref-type="bibr">19</xref>). It has been reported that the decrease in MMP is associated with the apoptosis of numerous types of cells (<xref rid="b23-mmr-0-0-12050" ref-type="bibr">23</xref>). JC-1 is a probe commonly used to detect the MMP of cells. When the MMP is high, JC-1 may accumulate in the mitochondrial matrix and form polymers to generate red fluorescence. When the MMP is low, the monomer state glows green. Following reperfusion, the cells were washed twice with PBS. Next, the cells were pretreated and stained according to the method of the MMP detection kit (Nanjing KeyGen Biotech Co., Ltd.). The fluorescence microscope (IX-73; Olympus Corporation; magnification, &#x00D7;200) detected the intensity of fluorescence in each group.</p>
</sec>
<sec>
<title>Intracellular [Ca<sup>2&#x002B;</sup>] measurement</title>
<p>Fluo-3 AM is the most commonly used for the detection of intracellular [Ca<sup>2&#x002B;</sup>]. Following reperfusion, the PC12 cells were washed twice with PBS and incubated with 5 &#x00B5;M/l Fluo-3/AM staining solution at 37&#x00B0;C for 30 min in the dark. Subsequently, the cells were washed twice with PBS. Next, with a fluorescence microscope (IX-73; Olympus Corporation; magnification, &#x00D7;200) to observe the fluorescence intensity.</p>
</sec>
<sec>
<title>Western blot analysis</title>
<p>The protein expression of Apaf-1, cleaved-caspase-7, procaspase-7, cleaved-caspase-3, procaspase-3, cleaved-caspase-9, procaspase-9, Bcl-2 and Bax in the cells following OGD/R injury were detected by Western blotting. Following treatment, cells were collected and cell lysates were prepared by incubation in RIPA buffer containing a protease inhibitor cocktail (Beijing Leagene Biotech Co., Ltd.) according to the manufacturer&#x0027;s protocols. Following protein concentration estimation using a BCA protein quantitation assay kit (Nanjing KeyGen Biotech Co., Ltd.), equal amounts (30 &#x00B5;g) of proteins were separated via 10&#x0025; SDS-PAGE, prior to being transferred to a PVDF membrane. The membranes were blocked with 5&#x0025; skimmed dry milk in tris-buffer solution (TBST) for 2 h at room temperature. Membranes were incubated with primary antibodies for overnight at 4&#x00B0;C, and the primary antibodies used were as follows: Bcl-2 (dilution, 1:1,000), Bax (dilution, 1:300), Apaf-1 (dilution, 1:300), procaspase-9 (dilution, 1:1,000), procaspase-7 (dilution, 1:500), procaspase-3 (dilution, 1:500), cleaved-caspase-3 (dilution, 1:500), cleaved-caspase-7 (dilution, 1:500), cleaved-caspase-9 (dilution, 1:500) and &#x03B1;-tubulin (dilution, 1:1,000). Next, labelled membranes were washed with TBST three times, and the membrane was probed with an HRP-labeled secondary antibody (dilution, 1:2,000; BIOSS) for 1 h at room temperature. The bands were then visualized using the Amersham Imager 600 imaging system (GE Healthcare Life Sciences).</p>
</sec>
<sec>
<title>Immunofluorescence detection</title>
<p>Immunofluorescence was detected to investigate the expression of Bcl-2 and Bax. Following reperfusion, the cells were washed 3 times with PBS, then post-fixed in 4&#x0025; paraformaldehyde at room temperature for 20 min and incubated in 0.3&#x0025; Triton X-100 for a further 20 min. Cells were washed with PBS and blocked with 1&#x0025; BSA at 37&#x00B0;C for 2 h. Next, Bcl-2 (dilution, 1:100) and Bax (dilution, 1:100) antibodies were added and incubated overnight. Cells were washed with PBS, fluorescent second antibody (dilution, 1:500) was added and incubated for 2 h in the dark at room temperature, the cells were washed 3 times with PBS, and DAPI (dilution, 1:500) was added for 30 min. Finally, cells were viewed using a fluorescence microscope (Olympus IX71; Olympus Corporation; magnification, &#x00D7;100).</p>
</sec>
<sec>
<title>Statistical analysis</title>
<p>The data were analyzed by Image Proplus and SPSS 17.0 software (SPSS, Inc.). Data are presented as the mean &#x00B1; standard deviation, and the changes in variable parameters were analyzed by one-way analysis of variance, followed by the Dunnett&#x0027;s test. P&#x003C;0.05 was considered to indicate a statistically significant difference.</p>
</sec>
</sec>
</sec>
<sec sec-type="results">
<title>Results</title>
<sec>
<title/>
<sec>
<title>Results of molecular docking</title>
<p>Molecular docking was used to predict the probable targets of CT. The docking results revealed a high affinity of CT towards Caspase-9, Caspase-3 and Caspase-7 (<xref rid="f2-mmr-0-0-12050" ref-type="fig">Fig. 2</xref>). Caspase-9 showed interactions between CT and Gly306, Leu307, Arg308, Val292, Arg294, Asp297, Val298 and Lys299 forming a hydrogen bond effect. Specifically, CT and an active site with residues Arg294 forms a hydrogen bond effect. Caspase-7 was interacting with CT through Val226, Pro227, Tyr229, Lys160, Thr163, Ala164, Tyr223 and Phe221. Specifically, CT and an active site with residues, Asn148, forms a hydrogen bond effect. CT was interacting with the Lys82, Leu81, Asn80, Lbu223, Lys224, Gln225, Ala227 and Asp228 residues of Caspase-3 form a strong hydrophobic effect. Specifically, CT and an active site with residues, Lys229, form a hydrogen bond effect.</p>
</sec>
<sec>
<title>Effect of CT on PC12 cell morphological changes</title>
<p>The results demonstrated that the number of PC12 cells significantly decreased following OGD/R treatment, certain cells became round or floating, and the cells exhibited typical swelling. Compared with the OGD/R group, in the OGD/R&#x002B;CT group (2.5, 5 and 10 &#x00B5;M), the cell body was relatively full, the membrane was smooth and intact, and the adhesion was good (<xref rid="f3-mmr-0-0-12050" ref-type="fig">Fig. 3</xref>). The results indicated that CT has a protective effect on PC12 cell injury induced by OGD/R.</p>
</sec>
<sec>
<title>Effect of CT on PC12 cell viability and cell cytotoxicity</title>
<p>As shown in <xref rid="f4-mmr-0-0-12050" ref-type="fig">Fig. 4A</xref>, PC12 cell viability was significantly decreased following the cell being exposed to OGD for 2 h and reperfusion for 24 h. Following treatment with CT (2.5 and 5 &#x00B5;M), PC12 cell viability was significantly increased (P&#x003C;0.05). LDH assays were performed as shown in <xref rid="f4-mmr-0-0-12050" ref-type="fig">Fig. 4B</xref>, and it was revealed that CT (2.5, 5 and 10 &#x00B5;M) significantly attenuated OGD/R-induced LDH leakage.</p>
</sec>
<sec>
<title>Effects of CT on apoptosis in PC12 cells</title>
<p>FITC-Annexin V/PI double staining was used with flow cytometry to analyze the anti-apoptotic capacity of CT under OGD/R conditions (<xref rid="f5-mmr-0-0-12050" ref-type="fig">Fig. 5</xref>). The results demonstrated that the cell apoptotic rate was significantly decreased following treatment with CT (2.5, 5 and 10 &#x00B5;M). The apoptotic cell rate with CT (10 &#x00B5;M) was higher than CT (5 &#x00B5;M), consistent with the effect of CT on the PC12 cell viability assay following OGD/R injury.</p>
</sec>
<sec>
<title>Effects of CT on MMP in PC12 cells</title>
<p>Fluorescence microscopy was used to detect MMP. Following treatment with the CT (2.5, 5 and 10 &#x00B5;M), red fluorescence increased in varying degrees, respectively, compared with the OGD/R group (<xref rid="f6-mmr-0-0-12050" ref-type="fig">Fig. 6</xref>).</p>
</sec>
<sec>
<title>Effects of CT on intracellular [Ca<sup>2&#x002B;</sup>] in PC12 cells</title>
<p>As a second messenger, [Ca<sup>2&#x002B;</sup>] regulates signal transduction and neurotransmitter release (<xref rid="b24-mmr-0-0-12050" ref-type="bibr">24</xref>,<xref rid="b25-mmr-0-0-12050" ref-type="bibr">25</xref>). Compared with the control group, the green fluorescence of the OGD/R group was very strong, which indicated that OGD/R increased the [Ca<sup>2&#x002B;</sup>] concentration in PC12 cells. The green fluorescence of cells treated with CT (2.5, 5 and 10 &#x00B5;M) was decreased, suggesting that CT decreased intracellular [Ca<sup>2&#x002B;</sup>] concentration. The results demonstrated that CT could inhibit the increase of intracellular [Ca<sup>2&#x002B;</sup>] induced by OGD/R injury (<xref rid="f7-mmr-0-0-12050" ref-type="fig">Fig. 7</xref>).</p>
</sec>
<sec>
<title>Effects of CT on the expression of Apaf-1, cleaved-Caspase-3, Caspase-3, cleaved-Caspase-7, Caspase-7, cleaved-Caspase-9, Caspase-9, Bax and Bcl-2 in PC12 cells following OGD/R</title>
<p>The expression of Bax and Apaf-1 were significantly increased following OGD/R. CT (2.5, 5 and 10 &#x00B5;M) inhibited the expression of Bax and Apaf-1. Additionally, following treatment of PC12 cells with OGD/R, the expression of Bcl-2 was decreased, treatment with CT (2.5, 5 and 10 &#x00B5;M) significantly attenuated the decrease in the Bcl-2 expression (<xref rid="f8-mmr-0-0-12050" ref-type="fig">Fig. 8</xref>).</p>
<p>In the present study, the expression of cleaved-Caspase-3, cleaved-Caspase-7, cleaved-Caspase-9, procaspase-3, procaspase-7 and procaspase-9 was investigated. As shown in <xref rid="f8-mmr-0-0-12050" ref-type="fig">Fig. 8</xref>, compared with the control group, the expression of cleaved-Caspase-9, cleaved-Caspase-3 and cleaved-Caspase-7 were significantly enhanced following OGD/R. CT (2.5, 5 and 10 &#x00B5;M) may markedly inhibit the expression of these proteins.</p>
</sec>
<sec>
<title>Detection of Bcl-2 and Bax in PC12 cells following OGD/R by cellular immunofluorescence</title>
<p>The expression of Bcl-2 protein was significantly decreased following OGD/R. However, following the intervention with CT (5 &#x00B5;M), red fluorescence was enhanced, which indicated that CT may improve the expression of Bcl-2 (<xref rid="f9-mmr-0-0-12050" ref-type="fig">Fig. 9</xref>). As shown in <xref rid="f9-mmr-0-0-12050" ref-type="fig">Fig. 9</xref>, the expression of Bax was notably increased following OGD/R compared with the control group. Compared with the OGD/R group, red fluorescence became weaker, which indicated that CT may inhibit the expression of Bax.</p>
</sec>
</sec>
</sec>
<sec sec-type="discussion">
<title>Discussion</title>
<p>Molecular docking is a drug design method that follows the characteristics of the receptor, and the interaction between the receptor and the drug molecule (<xref rid="b26-mmr-0-0-12050" ref-type="bibr">26</xref>). Proteins may undergo conformational transitions in physiological environments, and these transitions may stabilize following ligand binding (<xref rid="b27-mmr-0-0-12050" ref-type="bibr">27</xref>). Drugs are small compounds that act by binding to or interacting with a protein kinase. The intermolecular interactions between protein and medicines may be due to hydrophobic interactions, electrostatic and van der Waals forces (<xref rid="b28-mmr-0-0-12050" ref-type="bibr">28</xref>). The results demonstrated that CT contains binding sites with Caspase-9, Caspase-7 and Caspase-3. It suggested that these proteins may be the target of CT anti-apoptosis.</p>
<p>According to a previous study, the PC12 injury model induced by OGD/R is often used to mimic cerebral ischemia/reperfusion injury (<xref rid="b29-mmr-0-0-12050" ref-type="bibr">29</xref>). This model was used in the present study to investigate the effect and mechanisms of CT. The results demonstrated that CT may protect PC12 cells from OGD/R-induce injury by enhancing cell viability and inhibiting LDH leakage.</p>
<p>Apoptosis plays an essential role in maintaining metabolic balance and controlling neuron damage. Available evidence has suggested that apoptosis serves a significant role in the cerebral ischemia/reperfusion process (<xref rid="b30-mmr-0-0-12050" ref-type="bibr">30</xref>,<xref rid="b31-mmr-0-0-12050" ref-type="bibr">31</xref>). The results of the present study demonstrated that the number of apoptotic cells increased significantly following OGD/R. CT (2.5, 5 and 10 &#x00B5;M) significantly decreased apoptosis cells. However, the anti-apoptotic effect of 10 &#x00B5;M CT was not as significant as that of 5 &#x00B5;M CT. In early experiments on the cytotoxicity of CT on PC12 cells, it was found that after the CT dose increased to 10 &#x00B5;M, it became cytotoxic, which led to an increase in apoptosis. Therefore, it may cause the apoptotic cell rate with 10 &#x00B5;M CT to be higher than 5 &#x00B5;M CT, but the toxicity of 10 &#x00B5;M CT is minimal, and it has a specific protective effect on PC12 cells following OGD/R injury. Therefore, 5 &#x00B5;M CT has a better anti-apoptotic effect than 10 &#x00B5;M CT. MMP is a sensitive indicator reflecting mitochondrial function. The decrease in MMP leads to instability of neuronal cell structure, thereby causing cell damage and ultimately results in cell death (<xref rid="b22-mmr-0-0-12050" ref-type="bibr">22</xref>). A recent study has confirmed that OGD/R may cause intracellular [Ca<sup>2&#x002B;</sup>] overload and lead to mitochondrial dysfunction, resulting in unstable neuronal cell structure and ultimately leading to neuronal apoptosis (<xref rid="b32-mmr-0-0-12050" ref-type="bibr">32</xref>). Following treatment with OGD/R in PC12 cells, the MMP decreased, and the intracellular [Ca<sup>2&#x002B;</sup>] increased. However, CT decreased intracellular [Ca<sup>2&#x002B;</sup>] overload and enhanced MMP. These results indicated that CT has a protective role in PC12 cell injury induced by OGD/R.</p>
<p>A mitochondria-mediated apoptosis signalling pathway is one of the main pathways in the apoptotic of cerebral ischemia-reperfusion injury. The Bcl-2 protein family and its members form an incredibly complex network of interactions that regulate apoptosis. These proteins serve an essential role in regulating and controlling apoptosis (<xref rid="b33-mmr-0-0-12050" ref-type="bibr">33</xref>). Bcl-2 is an essential anti-apoptotic protein that may stabilize mitochondrial membrane function and prevent mitochondria release Cyto-c (<xref rid="b34-mmr-0-0-12050" ref-type="bibr">34</xref>). Bax is a pro-apoptotic protein in the cytoplasm under normal conditions. Bax increases the permeability of the mitochondrial membrane, which leads to the release of Cyto-c under certain stimulating conditions (<xref rid="b35-mmr-0-0-12050" ref-type="bibr">35</xref>,<xref rid="b36-mmr-0-0-12050" ref-type="bibr">36</xref>). Next, in the presence of dATP, Cyto-c binds to Apaf-1 to catalyze the activation of Caspase-9, and then activate downstream effector Caspases, including Caspase-3, Caspase-6 and Caspase-7, which in turn execute apoptosis by cleaving cellular proteins following specific Asp residues (<xref rid="b37-mmr-0-0-12050" ref-type="bibr">37</xref>). In the mitochondria-mediated pathway, Caspase-3 is the main influencing factor in the process of apoptosis, and its activation is a sign that the cell is entering an irreversible stage of apoptosis (<xref rid="b15-mmr-0-0-12050" ref-type="bibr">15</xref>). In the present study, the expression levels of Bcl-2 decreased, while the protein levels of Bax, Apaf-1, cleaved-Caspase-9, cleaved-Caspase-3 and cleaved-Caspase-7 significantly increased in OGD/R-treated PC12 cells. These results were consistent with those reported in the literature (<xref rid="b38-mmr-0-0-12050" ref-type="bibr">38</xref>,<xref rid="b39-mmr-0-0-12050" ref-type="bibr">39</xref>). Reversal of these CT trends suggested that the protective effect of CT may be associated with the inhibition of mitochondrial-mediated apoptosis in PC12 cells.</p>
<p>Costunolide had a protective effect against OGD/R-induced PC12 cell injury, and the mechanism may be associated with the inhibition of mitochondrial-mediated apoptosis.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgements</title>
<p>Not applicable.</p>
</ack>
<sec>
<title>Funding</title>
<p>The present study was supported by the National Natural Science Foundation of Ningxia (grant no. 2020AAC02017) and the National Natural Science Foundation of China (grant no. 81660700).</p>
</sec>
<sec sec-type="data-availability">
<title>Availability of data and materials</title>
<p>The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.</p>
</sec>
<sec>
<title>Authors&#x0027; contributions</title>
<p>LM, HM and JM established the PC12 cell injury model induced by OGD/R, and were responsible for detecting cell viability, LDH, [Ca<sup>2&#x002B;</sup>] concentration, mitochondrial membrane potential and protein expression. TL and HM analyzed and interpreted the data. LM wrote the manuscript. YZ and QZ designed the study, supervised the research group and revised the manuscript critically for important intellectual content. YZ and QZ confirmed the authenticity of all the raw data. The final version of the manuscript was read and approved by all authors.</p>
</sec>
<sec>
<title>Ethics approval and consent to participate</title>
<p>Not applicable.</p>
</sec>
<sec>
<title>Patient consent for publication</title>
<p>Not applicable.</p>
</sec>
<sec sec-type="COI-statement">
<title>Competing interests</title>
<p>The authors declare that they have no competing interests.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="b1-mmr-0-0-12050"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katan</surname><given-names>M</given-names></name><name><surname>Luft</surname><given-names>A</given-names></name></person-group><article-title>Global burden of stroke</article-title><source>Semin Neurol</source><volume>38</volume><fpage>208</fpage><lpage>211</lpage><year>2018</year><pub-id pub-id-type="doi">10.1055/s-0038-1649503</pub-id><pub-id pub-id-type="pmid">29791947</pub-id></element-citation></ref>
<ref id="b2-mmr-0-0-12050"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nitzsche</surname><given-names>A</given-names></name><name><surname>Poittevin</surname><given-names>M</given-names></name><name><surname>Benarab</surname><given-names>A</given-names></name><name><surname>Philippe Bonnin</surname><given-names>P</given-names></name><name><surname>Faraco</surname><given-names>G</given-names></name><name><surname>Uchida</surname><given-names>H</given-names></name><name><surname>Favre</surname><given-names>J</given-names></name><name><surname>Garcia-Bonilla</surname><given-names>L</given-names></name><name><surname>Garcia</surname><given-names>MCL</given-names></name><name><surname>L&#x00E9;ger</surname><given-names>PL</given-names></name><etal/></person-group><article-title>Endothelial S1P signaling counteracts infarct expansion in ischemic stroke</article-title><source>Circ Res</source><volume>128</volume><fpage>363</fpage><lpage>382</lpage><year>2021</year><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.120.316711</pub-id><pub-id pub-id-type="pmid">33301355</pub-id></element-citation></ref>
<ref id="b3-mmr-0-0-12050"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tu</surname><given-names>WJ</given-names></name><name><surname>Zeng</surname><given-names>XW</given-names></name><name><surname>Deng</surname><given-names>A</given-names></name><name><surname>Zhao</surname><given-names>SJ</given-names></name><name><surname>Luo</surname><given-names>DZ</given-names></name><name><surname>Ma</surname><given-names>GZ</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>Q</given-names></name></person-group><article-title>Circulating FABP4 (Fatty Acid-Binding Protein 4) is a novel prognostic biomarker in patients with acute ischemic stroke</article-title><source>Stroke</source><volume>48</volume><fpage>1531</fpage><lpage>1538</lpage><year>2017</year><pub-id pub-id-type="doi">10.1161/STROKEAHA.117.017128</pub-id><pub-id pub-id-type="pmid">28487339</pub-id></element-citation></ref>
<ref id="b4-mmr-0-0-12050"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brassai</surname><given-names>A</given-names></name><name><surname>Suvanjeiev</surname><given-names>RG</given-names></name><name><surname>B&#x00E1;n</surname><given-names>EG</given-names></name><name><surname>Lakatos</surname><given-names>M</given-names></name></person-group><article-title>Role of synaptic and nonsynaptic glutamate receptors in ischaemia induced neurotoxicity</article-title><source>Brain Res Bull</source><volume>112</volume><fpage>1</fpage><lpage>6</lpage><year>2015</year><pub-id pub-id-type="doi">10.1016/j.brainresbull.2014.12.007</pub-id><pub-id pub-id-type="pmid">25540918</pub-id></element-citation></ref>
<ref id="b5-mmr-0-0-12050"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maier</surname><given-names>O</given-names></name><name><surname>Menze</surname><given-names>BH</given-names></name><name><surname>Von der Gablentz</surname><given-names>J</given-names></name><name><surname>&#x1E26;ani</surname><given-names>L</given-names></name><name><surname>Heinrich</surname><given-names>MP</given-names></name><name><surname>Liebrand</surname><given-names>M</given-names></name><name><surname>Winzeck</surname><given-names>S</given-names></name><name><surname>Basit</surname><given-names>A</given-names></name><name><surname>Bentley</surname><given-names>P</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><etal/></person-group><article-title>ISLES 2015-A public evaluation benchmark for ischemic stroke lesion segmentation from multispectral MRI</article-title><source>Med Image Anal</source><volume>35</volume><fpage>250</fpage><lpage>269</lpage><year>2017</year><pub-id pub-id-type="doi">10.1016/j.media.2016.07.009</pub-id><pub-id pub-id-type="pmid">27475911</pub-id></element-citation></ref>
<ref id="b6-mmr-0-0-12050"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>J</given-names></name><name><surname>Bai</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>YX</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Xiong</surname><given-names>L</given-names></name><name><surname>Shi</surname><given-names>M</given-names></name><name><surname>Zhao</surname><given-names>G</given-names></name></person-group><article-title>Cinepazide maleate protects PC12 cells against oxygen-glucose deprivation-induced injury</article-title><source>Neurol Sci</source><volume>35</volume><fpage>875</fpage><lpage>881</lpage><year>2014</year><pub-id pub-id-type="doi">10.1007/s10072-013-1618-z</pub-id><pub-id pub-id-type="pmid">24374788</pub-id></element-citation></ref>
<ref id="b7-mmr-0-0-12050"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>QP</given-names></name><name><surname>Chen</surname><given-names>AL</given-names></name><name><surname>Wang</surname><given-names>XB</given-names></name><name><surname>Zhang</surname><given-names>ZH</given-names></name><name><surname>Zhao</surname><given-names>YH</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Ren</surname><given-names>SG</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name></person-group><article-title>Protective effects of dehydrocostuslactone on rat hippocampal slice injury induced by oxygen-glucose deprivation/reoxygenation</article-title><source>Int J Mol Med</source><volume>42</volume><fpage>1190</fpage><lpage>1198</lpage><year>2018</year><pub-id pub-id-type="pmid">29786748</pub-id></element-citation></ref>
<ref id="b8-mmr-0-0-12050"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>ZR</given-names></name><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Zhen</surname><given-names>J</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Lu</surname><given-names>ZN</given-names></name></person-group><article-title>Nobiletin protects PC12 cells from ERS-induced apoptosis in OGD/R injury via activation of the PI3K/AKT pathway</article-title><source>Exp Ther Med</source><volume>16</volume><fpage>1470</fpage><lpage>1476</lpage><year>2018</year><pub-id pub-id-type="pmid">30116396</pub-id></element-citation></ref>
<ref id="b9-mmr-0-0-12050"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meng</surname><given-names>X</given-names></name><name><surname>Xie</surname><given-names>W</given-names></name><name><surname>Xu</surname><given-names>Q</given-names></name><name><surname>Liang</surname><given-names>T</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Sun</surname><given-names>G</given-names></name><name><surname>Sun</surname><given-names>X</given-names></name></person-group><article-title>Neuroprotective effects of radix scrophulariae on cerebral ischemia and reperfusion injury via MAPK pathways</article-title><source>Molecules</source><volume>23</volume><fpage>2401</fpage><year>2018</year><pub-id pub-id-type="doi">10.3390/molecules23092401</pub-id></element-citation></ref>
<ref id="b10-mmr-0-0-12050"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kerr</surname><given-names>JF</given-names></name><name><surname>Searle</surname><given-names>J</given-names></name></person-group><article-title>A suggested explanation for the paradoxically slow growth rate of basal-cell carcinomas that contain numerous mitotic figures</article-title><source>J Pathol</source><volume>107</volume><fpage>41</fpage><lpage>44</lpage><year>1972</year><pub-id pub-id-type="doi">10.1002/path.1711070107</pub-id><pub-id pub-id-type="pmid">5069401</pub-id></element-citation></ref>
<ref id="b11-mmr-0-0-12050"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Green</surname><given-names>DR</given-names></name><name><surname>Kroemer</surname><given-names>G</given-names></name></person-group><article-title>The pathophysiology of mitochondrial cell death</article-title><source>Science</source><volume>305</volume><fpage>626</fpage><lpage>629</lpage><year>2004</year><pub-id pub-id-type="doi">10.1126/science.1099320</pub-id><pub-id pub-id-type="pmid">15286356</pub-id></element-citation></ref>
<ref id="b12-mmr-0-0-12050"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zamzami</surname><given-names>N</given-names></name><name><surname>Hirsch</surname><given-names>T</given-names></name><name><surname>Dallaporta</surname><given-names>B</given-names></name><name><surname>Petit</surname><given-names>PX</given-names></name><name><surname>Kroemer</surname><given-names>G</given-names></name></person-group><article-title>Mitochondrial implication in accidental and programmed cell death: Apoptosis and necrosis</article-title><source>J Bioenerg Biomembr</source><volume>29</volume><fpage>185</fpage><lpage>193</lpage><year>1997</year><pub-id pub-id-type="doi">10.1023/A:1022694131572</pub-id><pub-id pub-id-type="pmid">9239543</pub-id></element-citation></ref>
<ref id="b13-mmr-0-0-12050"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>XF</given-names></name><name><surname>Tian</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>P</given-names></name><name><surname>Zhang</surname><given-names>ZX</given-names></name></person-group><article-title>Expression of Cyt-c-mediated mitochondrial apoptosis-related proteins in rat renal proximal tubules during development</article-title><source>Nephron</source><volume>135</volume><fpage>77</fpage><lpage>86</lpage><year>2017</year><pub-id pub-id-type="doi">10.1159/000450585</pub-id><pub-id pub-id-type="pmid">27665619</pub-id></element-citation></ref>
<ref id="b14-mmr-0-0-12050"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malladi</surname><given-names>S</given-names></name><name><surname>Challa-Malladi</surname><given-names>M</given-names></name><name><surname>Fearnhead</surname><given-names>HO</given-names></name><name><surname>Bratton</surname><given-names>SB</given-names></name></person-group><article-title>The Apaf-1&#x002A;procaspase-9 apoptosome complex functions as a proteolytic-based molecular timer</article-title><source>EMBO J</source><volume>28</volume><fpage>1916</fpage><lpage>1925</lpage><year>2009</year><pub-id pub-id-type="doi">10.1038/emboj.2009.152</pub-id><pub-id pub-id-type="pmid">19494828</pub-id></element-citation></ref>
<ref id="b15-mmr-0-0-12050"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>Q</given-names></name><name><surname>Cheng</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Ma</surname><given-names>X</given-names></name></person-group><article-title>Neuroprotective effect and mechanism of Mu-Xiang-You-Fang on cerebral ischemia-reperfusion injury in rats</article-title><source>J Ethnopharmacol</source><volume>192</volume><fpage>140</fpage><lpage>147</lpage><year>2016</year><pub-id pub-id-type="doi">10.1016/j.jep.2016.07.016</pub-id><pub-id pub-id-type="pmid">27396346</pub-id></element-citation></ref>
<ref id="b16-mmr-0-0-12050"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>H</given-names></name><name><surname>He</surname><given-names>X</given-names></name><name><surname>Yang</surname><given-names>C</given-names></name></person-group><article-title>Costunolide promotes imatinib-induced apoptosis in chronic myeloid leukemia cells via the Bcr/Abl-Stat5 pathway</article-title><source>Phytother Res</source><volume>32</volume><fpage>1764</fpage><lpage>1769</lpage><year>2018</year><pub-id pub-id-type="doi">10.1002/ptr.6106</pub-id><pub-id pub-id-type="pmid">29701267</pub-id></element-citation></ref>
<ref id="b17-mmr-0-0-12050"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>D</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name></person-group><article-title>Costunolide ameliorates lipoteichoic acid-induced acute lung injury via attenuating MAPK signaling pathway</article-title><source>Int Immunopharmacol</source><volume>61</volume><fpage>283</fpage><lpage>289</lpage><year>2018</year><pub-id pub-id-type="doi">10.1016/j.intimp.2018.06.017</pub-id><pub-id pub-id-type="pmid">29906743</pub-id></element-citation></ref>
<ref id="b18-mmr-0-0-12050"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saraswati</surname><given-names>S</given-names></name><name><surname>Alhaider</surname><given-names>AA</given-names></name><name><surname>Abdelgadir</surname><given-names>AM</given-names></name></person-group><article-title>Costunolide suppresses inflammatory angiogenic response in a subcutaneous murine sponge model</article-title><source>APMIS</source><volume>126</volume><fpage>257</fpage><lpage>266</lpage><year>2018</year><pub-id pub-id-type="doi">10.1111/apm.12808</pub-id><pub-id pub-id-type="pmid">29484750</pub-id></element-citation></ref>
<ref id="b19-mmr-0-0-12050"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Jia</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>K</given-names></name><name><surname>Bao</surname><given-names>J</given-names></name><name><surname>Liang</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>M</given-names></name><etal/></person-group><article-title>Berberine protects against 6-OHDA-induced neurotoxicity in PC12 cells and zebrafish through hormetic mechanisms involving PI3K/AKT/Bcl-2 and Nrf2/HO-1 pathways</article-title><source>Redox Biol</source><volume>11</volume><fpage>1</fpage><lpage>11</lpage><year>2017</year><pub-id pub-id-type="doi">10.1016/j.redox.2016.10.019</pub-id><pub-id pub-id-type="pmid">27835779</pub-id></element-citation></ref>
<ref id="b20-mmr-0-0-12050"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>JF</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Shi</surname><given-names>LL</given-names></name><name><surname>Zhao</surname><given-names>ZH</given-names></name><name><surname>Xu</surname><given-names>H</given-names></name><name><surname>Liang</surname><given-names>F</given-names></name><name><surname>Li</surname><given-names>HB</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Yang</surname><given-names>K</given-names></name><name><surname>Tian</surname><given-names>YF</given-names></name></person-group><article-title>Parthenolide attenuates cerebral ischemia/reperfusion injury via Akt/GSK-3&#x03B2;pathway in PC12 cells</article-title><source>Biomed Pharmacother</source><volume>89</volume><fpage>1159</fpage><lpage>1165</lpage><year>2017</year><pub-id pub-id-type="doi">10.1016/j.biopha.2017.03.009</pub-id><pub-id pub-id-type="pmid">28314243</pub-id></element-citation></ref>
<ref id="b21-mmr-0-0-12050"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Wei</surname><given-names>W</given-names></name><name><surname>Lan</surname><given-names>XB</given-names></name><name><surname>Liu</surname><given-names>N</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Ma</surname><given-names>H</given-names></name><name><surname>Sun</surname><given-names>T</given-names></name><name><surname>Peng</surname><given-names>X</given-names></name><name><surname>Zhuang</surname><given-names>C</given-names></name><name><surname>Yu</surname><given-names>J</given-names></name></person-group><article-title>Neuroprotective effect of swertiamain on cerebral ischemia/reperfusion injury by inducing the Nrf2 protective pathway</article-title><source>ACS Chem Neurosci</source><volume>10</volume><fpage>2276</fpage><lpage>2286</lpage><year>2019</year><pub-id pub-id-type="doi">10.1021/acschemneuro.8b00605</pub-id><pub-id pub-id-type="pmid">30753053</pub-id></element-citation></ref>
<ref id="b22-mmr-0-0-12050"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>HX</given-names></name><name><surname>Hou</surname><given-names>F</given-names></name><name><surname>Chen</surname><given-names>AL</given-names></name><name><surname>Li</surname><given-names>TT</given-names></name><name><surname>Zhu</surname><given-names>YF</given-names></name><name><surname>Zhao</surname><given-names>QP</given-names></name></person-group><article-title>Mu-Xiang-You-Fang protects PC12 cells against OGD/R-induced autophagy via the AMPK/mTOR signaling pathway</article-title><source>J Ethnopharmacol</source><volume>252</volume><fpage>112583</fpage><year>2020</year><pub-id pub-id-type="doi">10.1016/j.jep.2020.112583</pub-id><pub-id pub-id-type="pmid">31978519</pub-id></element-citation></ref>
<ref id="b23-mmr-0-0-12050"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jangholi</surname><given-names>E</given-names></name><name><surname>Sharifi</surname><given-names>ZN</given-names></name><name><surname>Hoseinian</surname><given-names>M</given-names></name><name><surname>Zarrindast</surname><given-names>MR</given-names></name><name><surname>Rahimi</surname><given-names>HR</given-names></name><name><surname>Mowla</surname><given-names>A</given-names></name><name><surname>Aryan</surname><given-names>H</given-names></name><name><surname>Javidi</surname><given-names>MA</given-names></name><name><surname>Parsa</surname><given-names>Y</given-names></name><name><surname>Ghaffarpasand</surname><given-names>F</given-names></name><etal/></person-group><article-title>Verapamil inhibits mitochondria-induced reactive oxygen species and dependent apoptosis pathways in cerebral transient global ischemia/reperfusion</article-title><source>Oxid Med Cell Longev</source><volume>2020</volume><fpage>5872645</fpage><year>2020</year><pub-id pub-id-type="doi">10.1155/2020/5872645</pub-id><pub-id pub-id-type="pmid">33133347</pub-id></element-citation></ref>
<ref id="b24-mmr-0-0-12050"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farajdokht</surname><given-names>F</given-names></name><name><surname>Mohaddes</surname><given-names>G</given-names></name><name><surname>Karimi-Sales</surname><given-names>E</given-names></name><name><surname>Kafshdooz</surname><given-names>T</given-names></name><name><surname>Mahmoudi</surname><given-names>J</given-names></name><name><surname>Aberoumandi</surname><given-names>SM</given-names></name><name><surname>Karimi</surname><given-names>P</given-names></name></person-group><article-title>Inhibition of PTEN protects PC12 cells against oxygen-glucose deprivation induced cell death through mitoprotection</article-title><source>Brain Res</source><volume>1692</volume><fpage>100</fpage><lpage>109</lpage><year>2018</year><pub-id pub-id-type="doi">10.1016/j.brainres.2018.05.026</pub-id><pub-id pub-id-type="pmid">29787771</pub-id></element-citation></ref>
<ref id="b25-mmr-0-0-12050"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seta</surname><given-names>K</given-names></name><name><surname>Kim</surname><given-names>HW</given-names></name><name><surname>Ferguson</surname><given-names>T</given-names></name><name><surname>Kim</surname><given-names>R</given-names></name><name><surname>Pathrose</surname><given-names>P</given-names></name><name><surname>Yuan</surname><given-names>Y</given-names></name><name><surname>Lu</surname><given-names>G</given-names></name><name><surname>Spicer</surname><given-names>Z</given-names></name><name><surname>Millhorn</surname><given-names>DE</given-names></name></person-group><article-title>Genomic and physiological analysis of oxygen sensitivity and hypoxia tolerance in PC12 cells</article-title><source>Ann N Y Acad Sci</source><volume>971</volume><fpage>379</fpage><lpage>388</lpage><year>2002</year><pub-id pub-id-type="doi">10.1111/j.1749-6632.2002.tb04500.x</pub-id><pub-id pub-id-type="pmid">12438156</pub-id></element-citation></ref>
<ref id="b26-mmr-0-0-12050"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuntz</surname><given-names>ID</given-names></name><name><surname>Blaney</surname><given-names>JM</given-names></name><name><surname>Oatley</surname><given-names>SJ</given-names></name><name><surname>Langridge</surname><given-names>R</given-names></name><name><surname>Ferrin</surname><given-names>TE</given-names></name></person-group><article-title>A geometric approach to macromolecule-ligand interactions</article-title><source>J Mol Biol</source><volume>161</volume><fpage>269</fpage><lpage>288</lpage><year>1982</year><pub-id pub-id-type="doi">10.1016/0022-2836(82)90153-X</pub-id><pub-id pub-id-type="pmid">7154081</pub-id></element-citation></ref>
<ref id="b27-mmr-0-0-12050"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Overington</surname><given-names>JP</given-names></name><name><surname>Bissan</surname><given-names>AL</given-names></name><name><surname>Hopkins</surname><given-names>AL</given-names></name></person-group><article-title>How many drug targets are there?</article-title><source>Nat Rev Drug Discov</source><volume>5</volume><fpage>993</fpage><lpage>996</lpage><year>2006</year><pub-id pub-id-type="doi">10.1038/nrd2199</pub-id><pub-id pub-id-type="pmid">17139284</pub-id></element-citation></ref>
<ref id="b28-mmr-0-0-12050"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naqvi</surname><given-names>AAT</given-names></name><name><surname>Mohammad</surname><given-names>T</given-names></name><name><surname>Hasan</surname><given-names>GM</given-names></name><name><surname>Hassan</surname><given-names>MI</given-names></name></person-group><article-title>Advancements in docking and molecular dynamics simulations towards ligand-receptor interactions and structure-function relationships</article-title><source>Curr Top Med Chem</source><volume>8</volume><fpage>1755</fpage><lpage>1768</lpage><year>2018</year><pub-id pub-id-type="doi">10.2174/1568026618666181025114157</pub-id></element-citation></ref>
<ref id="b29-mmr-0-0-12050"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>LY</given-names></name><name><surname>Gao</surname><given-names>JM</given-names></name><name><surname>Liu</surname><given-names>YG</given-names></name><name><surname>Shi</surname><given-names>JS</given-names></name><name><surname>Gong</surname><given-names>Q</given-names></name></person-group><article-title>Icariside II alleviates oxygen-glucose deprivation and reoxygenation-induced PC12 cell oxidative injury by activating Nrf2/SIRT3 signaling pathway</article-title><source>Biomed Pharmacother</source><volume>103</volume><fpage>9</fpage><lpage>17</lpage><year>2018</year><pub-id pub-id-type="doi">10.1016/j.biopha.2018.04.005</pub-id><pub-id pub-id-type="pmid">29635133</pub-id></element-citation></ref>
<ref id="b30-mmr-0-0-12050"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Broughton</surname><given-names>BR</given-names></name><name><surname>Reutens</surname><given-names>DC</given-names></name><name><surname>Sobey</surname><given-names>CG</given-names></name></person-group><article-title>Apoptotic mechanisms after cerebral ischemia</article-title><source>Stroke</source><volume>40</volume><fpage>e331</fpage><lpage>e339</lpage><year>2009</year><pub-id pub-id-type="doi">10.1161/STROKEAHA.108.531632</pub-id><pub-id pub-id-type="pmid">19182083</pub-id></element-citation></ref>
<ref id="b31-mmr-0-0-12050"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>JR</given-names></name><name><surname>Tao</surname><given-names>YF</given-names></name><name><surname>Lou</surname><given-names>S</given-names></name><name><surname>Wu</surname><given-names>ZM</given-names></name></person-group><article-title>Protective effects of ginsenoside Rb(3) on oxygen and glucose deprivation-induced ischemic injury in PC12 cells</article-title><source>Acta Pharmacol Sin</source><volume>31</volume><fpage>273</fpage><lpage>280</lpage><year>2010</year><pub-id pub-id-type="doi">10.1038/aps.2010.9</pub-id><pub-id pub-id-type="pmid">20140005</pub-id></element-citation></ref>
<ref id="b32-mmr-0-0-12050"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Pablo</surname><given-names>Y</given-names></name><name><surname>Nilsson</surname><given-names>M</given-names></name><name><surname>Pekna</surname><given-names>M</given-names></name><name><surname>Pekny</surname><given-names>M</given-names></name></person-group><article-title>Intermediate filaments are important for astrocyte response to oxidative stress induced by oxygen-glucose deprivation and reperfusion</article-title><source>Histochem Cell Biol</source><volume>140</volume><fpage>81</fpage><lpage>91</lpage><year>2013</year><pub-id pub-id-type="doi">10.1007/s00418-013-1110-0</pub-id><pub-id pub-id-type="pmid">23756782</pub-id></element-citation></ref>
<ref id="b33-mmr-0-0-12050"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>YQ</given-names></name><name><surname>Liu</surname><given-names>JX</given-names></name><name><surname>Li</surname><given-names>XZ</given-names></name><name><surname>Xu</surname><given-names>L</given-names></name><name><surname>Xu</surname><given-names>YG</given-names></name></person-group><article-title>RNA interference-mediated downregulation of Beclin1 attenuates cerebral ischemic injury in rats</article-title><source>Acta Pharmacol Sin</source><volume>30</volume><fpage>919</fpage><lpage>927</lpage><year>2009</year><pub-id pub-id-type="doi">10.1038/aps.2009.79</pub-id><pub-id pub-id-type="pmid">19574998</pub-id></element-citation></ref>
<ref id="b34-mmr-0-0-12050"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>KW</given-names></name><name><surname>Cooper</surname><given-names>GM</given-names></name></person-group><article-title>Rapid turnover of mcl-1 couples translation to cell survival and apoptosis</article-title><source>J Biol Chem</source><volume>282</volume><fpage>6192</fpage><lpage>6200</lpage><year>2007</year><pub-id pub-id-type="doi">10.1074/jbc.M610643200</pub-id><pub-id pub-id-type="pmid">17200126</pub-id></element-citation></ref>
<ref id="b35-mmr-0-0-12050"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Parrish</surname><given-names>AB</given-names></name><name><surname>Kurokawa</surname><given-names>M</given-names></name><name><surname>Matsuura</surname><given-names>K</given-names></name><name><surname>Freel</surname><given-names>CD</given-names></name><name><surname>Andersen</surname><given-names>JL</given-names></name><name><surname>Johnson</surname><given-names>CE</given-names></name><name><surname>Kornbluth</surname><given-names>S</given-names></name></person-group><article-title>Rsk-mediated phosphorylation and 14-3-3&#x03B2;binding of Apaf-1 suppresses cytochrome c-induced apoptosis</article-title><source>EMBO J</source><volume>31</volume><fpage>1279</fpage><lpage>1292</lpage><year>2012</year><pub-id pub-id-type="doi">10.1038/emboj.2011.491</pub-id><pub-id pub-id-type="pmid">22246185</pub-id></element-citation></ref>
<ref id="b36-mmr-0-0-12050"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Zhu</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Ge</surname><given-names>Q</given-names></name><name><surname>Shen</surname><given-names>Y</given-names></name><name><surname>Pan</surname><given-names>S</given-names></name></person-group><article-title>Resveratrol protects PC12 cells against OGD/R-induced apoptosis via the mitochondrial-mediated signaling pathway</article-title><source>Acta Biochim Biophys Sin (Shanghai)</source><volume>48</volume><fpage>342</fpage><lpage>353</lpage><year>2016</year><pub-id pub-id-type="doi">10.1093/abbs/gmw011</pub-id><pub-id pub-id-type="pmid">26960953</pub-id></element-citation></ref>
<ref id="b37-mmr-0-0-12050"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boatright</surname><given-names>KM</given-names></name><name><surname>Salvesen</surname><given-names>GS</given-names></name></person-group><article-title>Mechanisms of caspase activation</article-title><source>Curr Opin Cell Biol</source><volume>15</volume><fpage>725</fpage><lpage>731</lpage><year>2003</year><pub-id pub-id-type="doi">10.1016/j.ceb.2003.10.009</pub-id><pub-id pub-id-type="pmid">14644197</pub-id></element-citation></ref>
<ref id="b38-mmr-0-0-12050"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>H</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Cui</surname><given-names>H</given-names></name><name><surname>Peng</surname><given-names>X</given-names></name><name><surname>Fang</surname><given-names>J</given-names></name><name><surname>Zuo</surname><given-names>Z</given-names></name><name><surname>Deng</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Wu</surname><given-names>B</given-names></name></person-group><article-title>Research advances on pathways of nickel-induced apoptosis</article-title><source>Int J Mol Sci</source><volume>17</volume><fpage>10</fpage><lpage>19</lpage><year>2015</year><pub-id pub-id-type="doi">10.3390/ijms17010010</pub-id></element-citation></ref>
<ref id="b39-mmr-0-0-12050"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haddad</surname><given-names>JJ</given-names></name></person-group><article-title>The role of Bax/Bcl-2 and pro-caspase peptides in hypoxia/reperfusion-dependent regulation of MAPKERK: Discordant proteomic effect of MAPK(p38)</article-title><source>Protein Pept Lett</source><volume>14</volume><fpage>361</fpage><lpage>371</lpage><year>2007</year><pub-id pub-id-type="doi">10.2174/092986607780363925</pub-id><pub-id pub-id-type="pmid">17504094</pub-id></element-citation></ref>
</ref-list>
</back>
<floats-group>
<fig id="f1-mmr-0-0-12050" position="float">
<label>Figure 1.</label>
<caption><p>Chemical structure of CT. The molecular formula for CT is C<sub>15</sub> H<sub>20</sub> O<sub>2</sub> and the molecular weight is 232.32 kD. CT, costunolide.</p></caption>
<graphic xlink:href="mmr-23-06-12050-g00.tif"/>
</fig>
<fig id="f2-mmr-0-0-12050" position="float">
<label>Figure 2.</label>
<caption><p>Molecular binding mode in the protein domains of CT docking. (A) Caspase-9, (B) Caspase-7 and (C) Caspase-3. Droplet shapes represent amino acid groups that interact with CT in 4&#x00C5;. Capital letters represent the abbreviation for amino acids. The numbers represent the numbering of amino acids in proteins. The line represents the CT in the protein cavity. The arrow mark indicates hydrogen bonding interactions between CT and protein domain residues. CT, costunolide.</p></caption>
<graphic xlink:href="mmr-23-06-12050-g01.tif"/>
</fig>
<fig id="f3-mmr-0-0-12050" position="float">
<label>Figure 3.</label>
<caption><p>Effect of CT on the morphology of the OGD/R injury model in PC12 cells (magnification, &#x00D7;200). The arrow points to the cells with morphological changes. CT, costunolide; OGD/R, oxygen-glucose deprivation/reperfusion.</p></caption>
<graphic xlink:href="mmr-23-06-12050-g02.tif"/>
</fig>
<fig id="f4-mmr-0-0-12050" position="float">
<label>Figure 4.</label>
<caption><p>Effects of CT on (A) cell survival and (B) LDH release in PC12 cells following OGD/R. Values are presented as the mean &#x00B1; standard deviation (n=10). <sup>#</sup>P&#x003C;0.05, compared with the control group; &#x002A;P&#x003C;0.05 and &#x002A;&#x002A;P&#x003C;0.01, compared with the OGD/R group. CT, costunolide; OGD/R, oxygen-glucose deprivation/reperfusion; OD, optical density; LDH, lactate dehydrogenase.</p></caption>
<graphic xlink:href="mmr-23-06-12050-g03.tif"/>
</fig>
<fig id="f5-mmr-0-0-12050" position="float">
<label>Figure 5.</label>
<caption><p>Effect of CT on the apoptotic rate following OGD/R in PC12 cells. (A) Cell apoptosis was determined by flow cytometry. (B) Quantitative analysis of apoptotic rate. Values are presented as the mean &#x00B1; standard deviation (n=3). <sup>#</sup>P&#x003C;0.05, compared with control group; &#x002A;P&#x003C;0.05, compared with the OGD/R group. CT, costunolide; OGD/R, oxygen-glucose deprivation/reperfusion.</p></caption>
<graphic xlink:href="mmr-23-06-12050-g04.tif"/>
</fig>
<fig id="f6-mmr-0-0-12050" position="float">
<label>Figure 6.</label>
<caption><p>Effect of CT on mitochondrial membrane potential in PC12 cells following OGD/R injury (magnification, &#x00D7;200). The left image shows the JC-1 aggregate form, the middle image shows the JC-1 monomer form, and the right image shows the merge of the left and central images. CT, costunolide; OGD/R, oxygen-glucose deprivation/reperfusion.</p></caption>
<graphic xlink:href="mmr-23-06-12050-g05.tif"/>
</fig>
<fig id="f7-mmr-0-0-12050" position="float">
<label>Figure 7.</label>
<caption><p>Effects of CT on intracellular [Ca<sup>2&#x002B;</sup>] concentration in PC12 cells following OGD/R injury (magnification, &#x00D7;200). The CT (2.5, 5 and 10 &#x00B5;M) decreased the intracellular [Ca<sup>2&#x002B;</sup>] concentration. CT, costunolide; OGD/R, oxygen-glucose deprivation/reperfusion.</p></caption>
<graphic xlink:href="mmr-23-06-12050-g06.tif"/>
</fig>
<fig id="f8-mmr-0-0-12050" position="float">
<label>Figure 8.</label>
<caption><p>Effects of CT on the expression of Apaf-1, Bcl-2, Bax, cleaved-Caspase-9, cleaved-Caspase-7, cleaved-Caspase-3 in PC12 cells following OGD/R. The stripe diagram represents Western blot analysis of Apaf-1, Bcl-2, Bax, cleaved-Caspase-9, cleaved-Caspase-7, cleaved-Caspase-3, procaspase-9, procaspase-7 and procaspase-3. &#x03B1;-tubulin was usedd as the loading control. The bar chart represents the quantitative analysis of Apaf-1, Bcl-2, Bax, cleaved-Caspase-9/procaspase-9, cleaved-Caspase-7/procaspase-7 and cleaved-Caspase-3/procaspase-3 expression. Values are presented as the mean &#x00B1; standard deviation (n=3). <sup>#</sup>P&#x003C;0.05, compared with the control group; &#x002A;P&#x003C;0.05, compared with OGD/R group. CT, costunolide; OGD/R, oxygen-glucose deprivation/reperfusion.</p></caption>
<graphic xlink:href="mmr-23-06-12050-g07.tif"/>
</fig>
<fig id="f9-mmr-0-0-12050" position="float">
<label>Figure 9.</label>
<caption><p>Effects of CT on the expression of Bcl-2 and Bax in PC12 cells following OGD/R (magnification, &#x00D7;100). The left image shows immunofluorescent staining with specific markers. The middle image shows the staining of the nucleus with DAPI. The right image shows the merge of the left and middle images. CT, costunolide; OGD/R, oxygen-glucose deprivation/reperfusion.</p></caption>
<graphic xlink:href="mmr-23-06-12050-g08.tif"/>
</fig>
</floats-group>
</article>
